Orphazyme A/S buy me8
Start price
23.08.21
/
0%
€4.98
Target price
23.08.22
€7.00
Performance (%)
-17.27%
End price
04.09.21
€4.12
Summary
This prediction ended on 04.09.21 with a price of €4.12. The prediction for Orphazyme A/S disappointed with a performance of -17.27%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Orphazyme A/S | - | - | - |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to me8 what are the pros and cons of Orphazyme A/S for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Cons
Little innovation
Comments by me8 for this prediction
In the thread Orphazyme A/s diskutieren
Buy Orphazyme A/S
Kursziel gesetzt auf 7,0
In the thread Trading Orphazyme A/s
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.